Jpmorgan Chase & CO Rocket Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 556,552 shares of RCKT stock, worth $5.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

556,552

Previous 579,738 4.0%

Holding current value

$5.79 Million

Previous $12.5 Million 17.64%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 26, 2024	SELL	$17.6 - $25.88 $408,073 - $600,053	-23,186 Reduced 4.0%	556,552 $10.3 Million
Q3 2024 Nov 08, 2024	SELL	$17.6 - $25.88 $408,073 - $600,053	-23,186 Reduced 4.0%	556,552 $10.3 Million
Q2 2024 Dec 26, 2024	BUY	$20.66 - $26.72 $479,022 - $619,529	23,186 Added 4.17%	579,738 $12.5 Million
Q2 2024 Aug 12, 2024	SELL	$20.66 - $26.72 $2.12 Million - $2.75 Million	-102,786 Reduced 15.06%	579,738 $12.5 Million
Q1 2024 Dec 26, 2024	BUY	$26.16 - $30.74 $3.3 Million - $3.87 Million	125,972 Added 22.63%	682,524 $18.4 Million
Q1 2024 May 10, 2024	SELL	$26.16 - $30.74 $1.72 Million - $2.02 Million	-65,816 Reduced 8.79%	682,524 $18.4 Million
Q4 2023 Dec 26, 2024	BUY	$16.78 - $31.94 $3.22 Million - $6.13 Million	191,788 Added 34.46%	748,340 $22.4 Million
Q4 2023 Feb 12, 2024	SELL	$16.78 - $31.94 $244,065 - $464,567	-14,545 Reduced 1.91%	748,340 $22.4 Million
Q3 2023 Nov 14, 2023	SELL	$15.07 - $24.05 $804,873 - $1.28 Million	-53,409 Reduced 6.54%	762,885 $15.6 Million
Q2 2023 Aug 11, 2023	SELL	$16.59 - $23.6 $82,634 - $117,551	-4,981 Reduced 0.61%	816,294 $16.2 Million
Q1 2023 May 18, 2023	BUY	$15.79 - $22.6 $1.13 Million - $1.61 Million	71,304 Added 9.51%	821,275 $14.1 Million
Q1 2023 May 11, 2023	SELL	$15.79 - $22.6 $1.54 Million - $2.2 Million	-97,350 Reduced 11.49%	749,971 $12.8 Million
Q4 2022 Feb 13, 2023	SELL	$15.5 - $22.76 $2.65 Million - $3.9 Million	-171,236 Reduced 16.81%	847,321 $16.6 Million
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $2.07 Million - $3.07 Million	166,963 Added 19.61%	1,018,557 $16.3 Million
Q2 2022 Aug 11, 2022	BUY	$7.96 - $16.64 $108,884 - $227,618	13,679 Added 1.63%	851,594 $11.7 Million
Q1 2022 May 11, 2022	BUY	$13.16 - $23.68 $2.04 Million - $3.66 Million	154,739 Added 22.65%	837,915 $13.3 Million
Q4 2021 Feb 10, 2022	SELL	$21.52 - $36.02 $2.99 Million - $5.01 Million	-138,959 Reduced 16.9%	683,176 $14.9 Million
Q3 2021 Nov 12, 2021	BUY	$27.42 - $48.97 $22.5 Million - $40.3 Million	822,135 New	822,135 $24.6 Million

Others Institutions Holding RCKT

# of Institutions

210

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $788M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Rocket Pharmaceuticals, Inc. Transaction History